{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:47:31Z","timestamp":1789040851133,"version":"build-2803163510"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Medication-related osteonecrosis of the jaw (ONJ) is rare adverse effect of zoledronic acid. We present ONJ detected in a 65-year-old man with prostate cancer who underwent <jats:sup>18<\/jats:sup>F-FDG PET\/CT for metabolic characterization and to exclude a second primary malignancy of the liver lesion observed in <jats:sup>68<\/jats:sup>Ga-PSMA PET\/CT. ONJ has high metabolic activity on <jats:sup>18<\/jats:sup>F-FDG PET\/CT and no PSMA receptor activation on the <jats:sup>68<\/jats:sup>Ga-PSMA PET\/CT. In this case, we wanted to underline the importance of <jats:sup>18<\/jats:sup>F-FDG PET\/CT imaging of medication-related ONJ in patients receiving zoledronic acid therapy and to emphasize that rapid and appropriate treatment can be provided.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004970","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T21:00:29Z","timestamp":1704315629000},"page":"e68-e69","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["A Comparison of 18F-FDG PET\/CT and 68Ga-PSMA PET\/CT in Detecting Osteonecrosis of the Jaw in a Patient With Prostate Cancer"],"prefix":"10.1097","volume":"49","author":[{"given":"Ahmet Ertu\u011frul","family":"\u00d6zt\u00fcrk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahime","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurhan","family":"Erg\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tevfik Fikret","family":"\u00c7ermik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,22]]},"reference":[{"key":"bib1-20250621","first-page":"32","article-title":"Prevalence of medication-related osteonecrosis of the jaw in patients with breast cancer, prostate cancer, and multiple myeloma","volume":"4","year":"2016","journal-title":"Dent J (Basel)"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.coms.2015.06.003","article-title":"The frequency of medication-related osteonecrosis of the jaw and its associated risk factors","volume":"27","year":"2015","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.joms.2015.10.025","article-title":"Does fluorodeoxyglucose positron emission tomography with computed tomography facilitate treatment of medication-related osteonecrosis of the jaw?","volume":"74","year":"2016","journal-title":"J Oral Maxillofac Surg"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.joms.2014.04.017","article-title":"Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw","volume":"72","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3174\/ajnr.A3355","article-title":"Bisphosphonate-induced osteonecrosis of the jaw: comparison of disease extent on contrast-enhanced MR imaging, [18F] fluoride PET\/CT, and conebeam CT imaging","volume":"34","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jdsr.2018.12.002","article-title":"Symposium: imaging modalities for drug-related osteonecrosis of the jaw (5), utility of bone scintigraphy and 18F-FDG PET\/CT in early detection and risk assessment of medication-related osteonecrosis of the jaw (secondary publication)","volume":"55","year":"2019","journal-title":"Jpn Dent Sci Rev"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/adj.12882","article-title":"Multiple myeloma masquerading as mandibular medication-related osteonecrosis of the jaw: a case report","volume":"67","year":"2022","journal-title":"Aust Dent J"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/RLU.0b013e318148b636","article-title":"Zoledronate-related osteonecrosis of the mandible","volume":"33","year":"2008","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:03:41Z","timestamp":1750532621000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,22]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004970","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,22]]}}}